Skip to main content
Clinical Trials/NCT01373021
NCT01373021
Completed
Phase 4

Assessment of the Effect of Dexmedetomidine in the Management of Postoperative Pain When Combined With Fentanyl in the Patient-controlled Analgesia

Seoul National University Hospital1 site in 1 country95 target enrollmentJune 2011

Overview

Phase
Phase 4
Intervention
Fentanyl
Conditions
Colon Cancer, Rectal Cancer
Sponsor
Seoul National University Hospital
Enrollment
95
Locations
1
Primary Endpoint
total amount of administered fentanyl
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this study is to determine whether additional Dexmedetomidine to patient controlled analgesia can reduce fentanyl consumption.

Registry
clinicaltrials.gov
Start Date
June 2011
End Date
February 2012
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yong Chul Kim

Professor

Seoul National University Hospital

Eligibility Criteria

Inclusion Criteria

  • Elective surgery for colon cancer

Exclusion Criteria

  • Liver disease
  • Kidney disease
  • Allergy for study drugs
  • Inability to receive patient controlled analgesia

Arms & Interventions

F

Fentanyl+Normal saline

Intervention: Fentanyl

D

Fentanyl+Dexmedetomidine

Intervention: Dexmedetomidine

Outcomes

Primary Outcomes

total amount of administered fentanyl

Time Frame: during first 24 hours after surgery

Study Sites (1)

Loading locations...

Similar Trials